← FDA Drug Approvals (Drugs@FDA)

ACETYLCYSTEINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EXELA PHARMA · Approved 2023-11-01

Drug application

FDA Application #

ANDA205643

Application type

Abbreviated New Drug Application (Generic)

Brand name

ACETYLCYSTEINE

Generic name

Acetylcysteine

Active ingredients

ACETYLCYSTEINE

Dosage form

SOLUTION

Route

INHALATION, ORAL

Marketing status

Discontinued

Sponsor

EXELA PHARMA

First approval

2023-11-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown